早期帕金森病的治疗挑战 - Suppr

Suppr

超能文献

Treatment challenges in early stage Parkinson's disease.

作者信息

Tetrud James

机构信息

The Parkinson's Institute, 1170 Morse Avenue, Sunnyvale, CA 94089, USA.

出版信息

Neurol Clin. 2004 Oct;22(3 Suppl):S19-33. doi: 10.1016/j.ncl.2004.05.002.

DOI:10.1016/j.ncl.2004.05.002

PMID:15501364

Abstract

摘要

相似文献

Treatment challenges in early stage Parkinson's disease.

Neurol Clin. 2004 Oct;22(3 Suppl):S19-33. doi: 10.1016/j.ncl.2004.05.002.

[The role of dopaminagonists in the treatment of Parkinson's disease].

Praxis (Bern 1994). 2005 Oct 19;94(42):1633-8. doi: 10.1024/0369-8394.94.42.1633.

Parkinson's disease.

Clin Evid. 2002 Jun(7):1208-20.

Future therapies for Parkinson's disease.

Neurol Clin. 2004 Oct;22(3 Suppl):S149-66. doi: 10.1016/j.ncl.2004.05.005.

Parkinson's disease.

Clin Evid. 2002 Dec(8):1370-85.

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.

Mov Disord. 2000 May;15(3):485-9.

Treatment of drug-induced psychosis in Parkinson's disease with clozapine.

Adv Neurol. 1993;60:703-6.

Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease.

Mov Disord. 1998 Jul;13(4):731-4. doi: 10.1002/mds.870130421.

[Therapy of Parkinson disease. 1: Standard therapy of motor and non-motor symptoms].

Fortschr Neurol Psychiatr. 1997 Aug;65(8):361-74. doi: 10.1055/s-2007-996341.

[Diagnosis and therapy of Parkinson's disease].

MMW Fortschr Med. 2005 May 17;147 Spec No 2:28-31.

引用本文的文献

Perceived social support in the daily life of people with Parkinson's disease: a distinct role and potential classifier.

Sci Rep. 2025 Jul 24;15(1):26880. doi: 10.1038/s41598-025-12787-w.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Treatment challenges in early stage Parkinson's disease.

作者信息

Tetrud James

机构信息

The Parkinson's Institute, 1170 Morse Avenue, Sunnyvale, CA 94089, USA.

出版信息

Neurol Clin. 2004 Oct;22(3 Suppl):S19-33. doi: 10.1016/j.ncl.2004.05.002.

DOI:10.1016/j.ncl.2004.05.002

PMID:15501364

Abstract

摘要

相似文献

Treatment challenges in early stage Parkinson's disease.

Neurol Clin. 2004 Oct;22(3 Suppl):S19-33. doi: 10.1016/j.ncl.2004.05.002.

[The role of dopaminagonists in the treatment of Parkinson's disease].

Praxis (Bern 1994). 2005 Oct 19;94(42):1633-8. doi: 10.1024/0369-8394.94.42.1633.

Parkinson's disease.

Clin Evid. 2002 Jun(7):1208-20.

Future therapies for Parkinson's disease.

Neurol Clin. 2004 Oct;22(3 Suppl):S149-66. doi: 10.1016/j.ncl.2004.05.005.

Parkinson's disease.

Clin Evid. 2002 Dec(8):1370-85.

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.

Mov Disord. 2000 May;15(3):485-9.

Treatment of drug-induced psychosis in Parkinson's disease with clozapine.

Adv Neurol. 1993;60:703-6.

Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease.

Mov Disord. 1998 Jul;13(4):731-4. doi: 10.1002/mds.870130421.

[Therapy of Parkinson disease. 1: Standard therapy of motor and non-motor symptoms].

Fortschr Neurol Psychiatr. 1997 Aug;65(8):361-74. doi: 10.1055/s-2007-996341.

[Diagnosis and therapy of Parkinson's disease].

MMW Fortschr Med. 2005 May 17;147 Spec No 2:28-31.

引用本文的文献

Perceived social support in the daily life of people with Parkinson's disease: a distinct role and potential classifier.

Sci Rep. 2025 Jul 24;15(1):26880. doi: 10.1038/s41598-025-12787-w.